Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium

Immunology

Volumn 130, Issue 3, 2010, Pages 388-398

  Fernandez Cabezudo, Maria J ^a   Lorke, Dietrich E ^a,b   Azimullah, Sheikh ^a   Mechkarska, Milena ^a   Hasan, Mohammed Y ^a   Petroianu, Georg A ^a   Al Ramadi, Basel K ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Acetylcholine; Cholinergic anti inflammatory pathway; Innate immunity; Organophosphate; Salmonella infection

Indexed keywords

ACETYLCHOLINESTERASE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; OXIME DERIVATIVE; PARAOXON;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREACTIVITY; INFECTION RESISTANCE; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLOSIS; SURVIVAL;

ACETYLCHOLINESTERASE; ANIMALS; B-LYMPHOCYTES; CELL COUNT; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; CONCANAVALIN A; CYTOKINES; ERYTHROCYTES; IMMUNE SYSTEM; LIPOPOLYSACCHARIDES; LYMPH NODES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; OXIMES; PARAOXON; PYRIDINIUM COMPOUNDS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 77953510237     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03238.x     Document Type: Article

References (54)

1. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003 8 : 125 134.
2. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007 117 : 289 296.
3. Gallowitsch-Puerta M, Pavlov VA. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 2007 25 : 2325 2329.
4. Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000 405 : 458 462.
5. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003 421 : 384 388.
6. Van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, Van der Poll T. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006 130 : 1822 1830.
7. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006 131 : 1122 1130.
8. Van Der Zanden EP, Boeckxstaens GE, De Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009 21 : 6 17.
9. Kessler W, Traeger T, Westerholt A, Neher F, Mikulcak M, Muller A, Maier S, Heidecke CD. The vagal nerve as a link between the nervous and immune system in the instance of polymicrobial sepsis. Langenbecks Arch Surg 2006 391 : 83 7.
10. Wang H, Liao H, Ochani M et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004 10 : 1216 1221.
11. Van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, De Vos AF, Tracey KJ, Van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005 191 : 2138 2148.
12. Akinci SB, Ulu N, Yondem OZ, Firat P, Guc MO, Kanbak M, Aypar U. Effect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathway. World J Surg 2005 29 : 1483 1489.
13. Hofer S, Eisenbach C, Lukic IK et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008 36 : 404 408.
14. Fernandez-Cabezudo MJ, Azimullah S, Nurulain SM, Mechkarska M, Lorke DE, Hasan MY, Petroianu GA, Al-Ramadi BK. The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure. Int J Immunopathol Pharmacol 2008 21 : 891 901.
15. Petroianu G, Toomes LM, Petroianu A, Bergler W, Rufer R. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J Appl Toxicol 1998 18 : 293 298.
16. Buckley NA, Eddleston M, Szinicz L. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2005 : CD005085.
17. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006 34 : 502 510.
18. Petroianu GA, Lorke DE. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in vitro testing for in vivo efficacy. Mini Rev Med Chem 2008 8 : 1328 1342.
19. Kuca K, Bielavsky J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003 13 : 3545 3547.
20. Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008 15 : 743 753.
21. Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MA, Kuca K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 2006 26 : 262 268.
22. al-Ramadi BK, Fernandez-Cabezudo MJ, Ullah A, El-Hasasna H, Flavell RA. CD154 is essential for protective immunity in experimental Salmonella infection: evidence for a dual role in innate and adaptive immune responses. J Immunol 2006 176 : 496 506.
23. Eisenstein TK, Killar LM, Sultzer BM. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis 1984 150 : 425 435.
24. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun 1993 61 : 3981 3984.
25. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, Maskell DJ, Dougan G, Hormaeche CE. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 1998 66 : 4767 4776.
26. Lehmann J, Bellmann S, Werner C, Schroder R, Schutze N, Alber G. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J Immunol 2001 167 : 5304 5315.
27. Filipe-Santos O, Bustamante J, Chapgier A et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006 18 : 347 361.
28. Price JD, Simpfendorfer KR, Mantena RR, Holden J, Heath WR, Van Rooijen N, Strugnell RA, Wijburg OL. Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium. Infect Immun 2007 75 : 5753 5762.
29. al-Ramadi BK, Al-Dhaheri MH, Mustafa N, Abouhaidar M, Xu D, Liew FY, Lukic ML, Fernandez-Cabezudo MJ. Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor α. Infect Immun 2001 69 : 3980 3988.
30. Fernandez-Cabezudo MJ, Ali SAE, Ullah A, Hasan MY, Kosanovic M, Fahim MA, Adem A, al-Ramadi BK. Pronounced susceptibility to infection by Salmonella enterica serovar Typhimurium in mice chronically exposed to lead correlates with a shift to Th2-type immune responses. Toxicol Appl Pharmacol 2007 218 : 215 226.
31. Van Kampen EJ, Zijlstra WG. Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin Chim Acta 1961 6 : 538 544.
32. Fernandez-Cabezudo MJ, Mechkarska M, Azimullah S, al-Ramadi BK. Modulation of macrophage proinflammatory functions by cytokine-expressing Salmonella vectors. Clin Immunol 2009 130 : 51 60.
33. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986 83 : 5189 5193.
34. Mastroeni P, Sheppard M. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 2004 6 : 398 405.
35. Waxman S (ed.). Clinical Neuroanatomy, 25th edn.
36. Kawashima K, Yoshikawa K, Fujii YX, Moriwaki Y, Misawa H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 2007 25 : 2314 2319.
37. Saeed RW, Varma S, Peng-Nemeroff T et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005 201 : 1113 1123.
38. Pavlov VA, Tracey KJ. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 2004 61 : 2322 2331.
39. Tracey KJ. The inflammatory reflex. Nature 2002 420 : 853 859.
40. De Jonge WJ, Van der Zanden EP, The FO et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005 6 : 844 851.
41. Huston JM, Ochani M, Rosas-Ballina M et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006 203 : 1623 1628.
42. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S, Tracey KJ. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008 105 : 11008 11013.
43. Fernandez-Cabezudo MJ, Ullah A, Flavell RA, Al-Ramadi BK. Evidence for the requirement for CD40-CD154 interactions in resistance to infections with attenuated Salmonella. J Endotoxin Res 2005 11 : 395 399.
44. -/- (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000 68 : 46 53.
45. McSorley SJ, Jenkins MK. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun 2000 68 : 3344 3348.
46. Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuca K, Petroianu GA. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. J Appl Toxicol 2007 27 : 482 490.
47. Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Sha Ullah M, Naseer O. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. J Appl Toxicol 2005 25 : 68 73. (Pubitemid 40194002)
48. Joosen MJ, Van Helden HP. Correlations between acetylcholinesterase inhibition, acetylcholine levels and EEG changes during perfusion with neostigmine and N6-cyclopentyladenosine in rat brain. Eur J Pharmacol 2007 3 : 122 128.
49. Eigenberg DA, Pazdernik TL, Doull J. Hemoperfusion and pharmacokinetic studies with parathion and paraoxon in the rat and dog. Drug Metab Dispos 1983 11 : 366 370. (Pubitemid 13035488)
50. Richter-Dahlfors A, Buchan AM, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997 186 : 569 580.
51. Schafer R, Eisenstein TK. Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect Immun 1992 60 : 791 797.
52. al-Ramadi BK, Mustafa N, AbouHaidar M, Fernandez-Cabezudo MJ. Induction of innate immunity by IL-2-expressing Salmonella confers protection against lethal infection. Mol Immunol 2003 39 : 763 770.
53. Laskay T, Diefenbach A, Rollinghoff M, Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur J Immunol 1995 25 : 2220 2227.
54. Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995 154 : 5320 5330.